Tag: drug companies U.S. manufacturing

In a dramatic escalation of transatlantic trade tensions, the United States has announced plans to impose 100 % tariffs on branded pharmaceutical imports, unless companies build manufacturing facilities in the U.S. beginning October 1, 2025. The European Union, however, is pushing back confidently, citing a recent trade agreement with the U.S. which it claims caps…